162 related articles for article (PubMed ID: 34118839)
1. Effectiveness and safety of tibial nerve stimulation versus anticholinergic drugs for the treatment of overactive bladder syndrome: a meta-analysis.
Xiong SC; Peng L; Hu X; Shao YX; Wu K; Li X
Ann Palliat Med; 2021 Jun; 10(6):6287-6296. PubMed ID: 34118839
[TBL] [Abstract][Full Text] [Related]
2. Non-inferior and more feasible transcutaneous tibial nerve stimulation in treating overactive bladder: A systematic review and meta-analysis.
Alomari MS; Abdulhamid AS; Ghaddaf AA; Alshareef KM; Haneef AK; AlQuhaibi MS; Banjar RA
Int J Urol; 2022 Oct; 29(10):1170-1180. PubMed ID: 35711082
[TBL] [Abstract][Full Text] [Related]
3. Pooled analysis of the efficacy and safety of tibial nerve stimulation versus antimuscarinic agents in the management of overactive bladder syndrome.
Xia L; Yan H; Sun Y; Zhu Y; Wu Y; Chen Z; Su S
Medicine (Baltimore); 2021 Nov; 100(45):e27745. PubMed ID: 34766587
[TBL] [Abstract][Full Text] [Related]
4. Percutaneous tibial nerve stimulation for overactive bladder syndrome: a systematic review and meta-analysis.
Wang M; Jian Z; Ma Y; Jin X; Li H; Wang K
Int Urogynecol J; 2020 Dec; 31(12):2457-2471. PubMed ID: 32681345
[TBL] [Abstract][Full Text] [Related]
5. Treatment for overactive bladder: A meta-analysis of tibial versus parasacral neuromodulation.
Wang ZH; Liu ZH
Medicine (Baltimore); 2022 Oct; 101(41):e31165. PubMed ID: 36253991
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of percutaneous and transcutaneous posterior tibial nerve stimulation on idiopathic overactive bladder and interstitial cystitis/painful bladder syndrome: A systematic review and meta-analysis.
Ghavidel-Sardsahra A; Ghojazadeh M; Rahnama'I MS; Naseri A; Yazdandoost S; Khezerloo T; Seyedi-Sahebari S; Hosseinifard H; Vahed N; Mostafaei H; Salehi-Pourmehr H; Hajebrahimi S
Neurourol Urodyn; 2022 Feb; 41(2):539-551. PubMed ID: 35032328
[TBL] [Abstract][Full Text] [Related]
7. Which anticholinergic drug for overactive bladder symptoms in adults.
Madhuvrata P; Cody JD; Ellis G; Herbison GP; Hay-Smith EJ
Cochrane Database Syst Rev; 2012 Jan; 1():CD005429. PubMed ID: 22258963
[TBL] [Abstract][Full Text] [Related]
8. Tibial Nerve Stimulation for Urge Urinary Incontinence and Overactive Bladder: Narrative Review of Randomized Controlled Trials and Applicability to Implantable Devices.
Lee UJ; MacDiarmid S; Matthews CA; Gillespie E; Peters KM
Adv Ther; 2024 Jul; 41(7):2635-2654. PubMed ID: 38748331
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of overactive neurogenic bladder treatment: A systematic review of randomized controlled trials.
Bapir R; Bhatti KH; Eliwa A; García-Perdomo HA; Gherabi N; Hennessey D; Magri V; Mourmouris P; Ouattara A; Perletti G; Philipraj J; Stamatiou K; Trinchieri A; Buchholz N
Arch Ital Urol Androl; 2022 Dec; 94(4):492-506. PubMed ID: 36576454
[TBL] [Abstract][Full Text] [Related]
10. Treatment for overactive bladder: A meta-analysis of transcutaneous tibial nerve stimulation versus percutaneous tibial nerve stimulation.
Yang DY; Zhao LN; Qiu MX
Medicine (Baltimore); 2021 May; 100(20):e25941. PubMed ID: 34011072
[TBL] [Abstract][Full Text] [Related]
11. [Results and compliance of transcutaneous tibial nerve stimulation on overactive bladder syndrome in patients with Parkinson's disease. Retrospective Study.].
Charvolin L; Guinet-Lacoste A; Waz D; Godmer M; Rode G
Prog Urol; 2019 Jul; 29(7):378-384. PubMed ID: 30876700
[TBL] [Abstract][Full Text] [Related]
12. The effectiveness of different electrical nerve stimulation protocols for treating adults with non-neurogenic overactive bladder: a systematic review and meta-analysis.
Zomkowski K; Kammers I; Back BBH; Moreira GM; Sonza A; Sacomori C; Sperandio FF
Int Urogynecol J; 2022 May; 33(5):1045-1058. PubMed ID: 35119495
[TBL] [Abstract][Full Text] [Related]
13. Treatments for overactive bladder: focus on pharmacotherapy.
Geoffrion R;
J Obstet Gynaecol Can; 2012 Nov; 34(11):1092-1101. PubMed ID: 23231848
[TBL] [Abstract][Full Text] [Related]
14. Anticholinergic drugs versus non-drug active therapies for overactive bladder syndrome in adults.
Alhasso AA; McKinlay J; Patrick K; Stewart L
Cochrane Database Syst Rev; 2006 Oct; (4):CD003193. PubMed ID: 17054163
[TBL] [Abstract][Full Text] [Related]
15. Effects of percutaneous tibial nerve stimulation on adult patients with overactive bladder syndrome: a systematic review.
Moossdorff-Steinhauser HF; Berghmans B
Neurourol Urodyn; 2013 Mar; 32(3):206-14. PubMed ID: 22907807
[TBL] [Abstract][Full Text] [Related]
16. Long-term durability of percutaneous tibial nerve stimulation for the treatment of overactive bladder.
MacDiarmid SA; Peters KM; Shobeiri SA; Wooldridge LS; Rovner ES; Leong FC; Siegel SW; Tate SB; Feagins BA
J Urol; 2010 Jan; 183(1):234-40. PubMed ID: 19913821
[TBL] [Abstract][Full Text] [Related]
17. A novel leadless, miniature implantable Tibial Nerve Neuromodulation System for the management of overactive bladder complaints.
Heesakkers JPFA; Digesu GA; van Breda J; Van Kerrebroeck P; Elneil S
Neurourol Urodyn; 2018 Mar; 37(3):1060-1067. PubMed ID: 28892221
[TBL] [Abstract][Full Text] [Related]
18. Is imidafenacin an alternative to current antimuscarinic drugs for patients with overactive bladder syndrome?
Wu JP; Peng L; Zeng X; Li H; Shen H; Luo DY
Int Urogynecol J; 2021 May; 32(5):1117-1127. PubMed ID: 32405660
[TBL] [Abstract][Full Text] [Related]
19. The effectiveness of transcutaneous tibial nerve stimulation (TTNS) for adults with overactive bladder syndrome: A systematic review.
Booth J; Connelly L; Dickson S; Duncan F; Lawrence M
Neurourol Urodyn; 2018 Feb; 37(2):528-541. PubMed ID: 28731583
[TBL] [Abstract][Full Text] [Related]
20. Randomized trial of percutaneous tibial nerve stimulation versus extended-release tolterodine: results from the overactive bladder innovative therapy trial.
Peters KM; Macdiarmid SA; Wooldridge LS; Leong FC; Shobeiri SA; Rovner ES; Siegel SW; Tate SB; Jarnagin BK; Rosenblatt PL; Feagins BA
J Urol; 2009 Sep; 182(3):1055-61. PubMed ID: 19616802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
